Case ReportNeuroendocrine Small Cell Carcinoma of the Uterine Cervix: What Disease? What Treatment? Report of Ten Cases and a Review of the Literature
References (40)
- et al.
Neuroendocrine carcinoma of the cervix: implications for staging and therapy
Gynecol Oncol
(1981) - et al.
An immunohistochemical study of small-cell and poorly differentiated carcinomas of the cervix using neuroendocrine markers
Gynecol Oncol
(1989) - et al.
Successful treatment of neuroendocrine small cell carcinoma of the cervix metastatic to regional lymph nodes
Gynecol Oncol
(1996) - et al.
Small cell neuroendocrine carcinoma of the cervix with involvement of multiple pelvic nodes a successfully treated case by multimodal approach
Gynecol Oncol
(1999) - et al.
Small cell carcinoma of the cervix treated with concurrent radiotherapy, cisplatin and etoposide
Gynecol Oncol
(1995) - et al.
A potential role for intensive chemotherapy in the treatment of small cell neuroendocrine tumors of the cervix
Gynecol Oncol
(1993) - et al.
Small cell carcinoma of the cervix: a clinical and flow-cytometric study
Gynecol Oncol
(1991) - et al.
Small cell carcinoma of the cervix
Clin Oncol
(1996) - et al.
Molecular abnormalities associated with endocrine tumors of the uterine cervix
Gynecol Oncol
(1999) - et al.
Neuroendocrine small cell uterine cervix cancer during pregnancy: long-term survival following combined therapy
Gynecol Oncol
(1998)
Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide
Gynecol Oncol
Adjuvant therapy for neuroendocrine small cell carcinoma of the cervix: review of the literature
Gynecol Oncol
Small cell carcinoma of the uterine cervix
Cancer
Efficacy of radical hysterectomy as treatment for patients with small cell carcinoma of the cervix
Cancer
Neuroendocrine features in poorly differentiated and undifferentiated carcinomas of the cervix
Cancer
Small cell carcinoma of the uterine cervix: pathology and prognostic factors
Surg Pathol
Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute
Arch Pathol Lab Med
Therapeutic implications of patterns of recurrence in cancer of the uterine cervix
Cancer
Surgically treated, early-stage neuroendocrine small-cell cervical carcinoma
Obstet Gynecol
Cited by (48)
The puzzle of gynecologic neuroendocrine carcinomas: State of the art and future directions
2021, Critical Reviews in Oncology/HematologyChapter 15 - Neuroendocrine Carcinoma, Mixed Epithelial/Mesenchymal and Mesenchymal Tumors, and Miscellaneous Lesions of the Cervix
2018, Diagnostic Gynecologic and Obstetric PathologyNeuroendrocrine tumors of the uterine cervix: A therapeutic challenge for gynecologic oncologists
2017, Gynecologic OncologyCitation Excerpt :For this reason, the therapeutic approach is mainly adapted from that of lung SCNEC, giving the histological similarity between these two entities. It consists of a multimodality treatment even in early-stage patients, since they may develop distant metastases [33,36–39,41,48,49,60–62]. In fact, loco-regional treatment alone has revealed to be inadequate to control both the local disease and the distant metastases [5,7,53].
Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India
2013, Annals of Diagnostic PathologyCitation Excerpt :Neuron-specific enolase and CD56 showed high sensitivity. Abeler et al [10] observed neuroendocrine differentiation in 79% tumors, whereas Delaloge et al [16] substantiated neuroendocrine differentiation by IHC in their all 10 study cases (100%). These studies revealed maximum positivity with NSE, followed by synaptophysin and chromogranin.
Neuroendocrine carcinoma of the uterine cervix: 15-year experience from a tertiary care centre in Southern India
2021, Journal of Radiotherapy in Practice